Downregulation of HtrA1 protein is associated with poor survival in mesothelioma [52], hepatocellular carcinoma [53], and breast cancer [54]; in the latter study, nodepositivity was associated with shorter survival. This evidence concerns the gene HTRA1 and breast cancer.